Cargando…

Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda

INTRODUCTION: Maternal red cell alloimmunization to Rh antigen in pregnant women occurs when the immune system is sensitized by foreign red blood cell surface antigens, in this case fetal red blood cells, inducing an immune response. Various antigens of blood group systems may cause alloimmunization...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbalibulha, Yona, Natukunda, Bernard, Okwi, Andrew Livex, Kalyango, Joan N, Isaac, Kajja, Ononge, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719281/
https://www.ncbi.nlm.nih.gov/pubmed/36471679
http://dx.doi.org/10.2147/JBM.S385737
_version_ 1784843287619698688
author Mbalibulha, Yona
Natukunda, Bernard
Okwi, Andrew Livex
Kalyango, Joan N
Isaac, Kajja
Ononge, Sam
author_facet Mbalibulha, Yona
Natukunda, Bernard
Okwi, Andrew Livex
Kalyango, Joan N
Isaac, Kajja
Ononge, Sam
author_sort Mbalibulha, Yona
collection PubMed
description INTRODUCTION: Maternal red cell alloimmunization to Rh antigen in pregnant women occurs when the immune system is sensitized by foreign red blood cell surface antigens, in this case fetal red blood cells, inducing an immune response. Various antigens of blood group systems may cause alloimmunization, especially the Rh, Kel, Fy, JK, and MNS systems. This study aimed to determine alloimmunization to the different frequencies of Rh antigen among pregnant women in South Western Uganda. METHODS: A total of 1369 pregnant women consented and were recruited into a cross-sectional study during their regular antenatal visits during the period August 2020 to July 2021. Samples (4 mL) of anticoagulated and coagulated blood were obtained, and Rh blood grouping including Rh antigen and the indirect antiglobulin test (IAT) was carried out using the agglutination technology of the LISS ID-Card technique in the Ortho Biovue ID-Micro Typing System. RESULTS: Out of 1369 participants recruited to the study, 78 (5.7%) were D(−), 1291 were D(+), and 134 (9.8%) had alloantibodies. Among those with alloantibodies, 115 (85.8%) were D(+) and 19 (14.2%) D(−). The percentage alloimmunization according to the Rh antigens was highest in e (9.72%), c (2.48%), C (2.34%) and E (0.94%) antigens. With the ABO system, alloimmunization was highest in blood group B (10.7%), followed by A (10.6%), O (9.2%) and then AB (7.1%). Alloimmunization was more prevalent in D(−) (24%) than in D(+) participants (8.9%). Rhesus antigen e was the most prevalent antigen (99.8%), followed by c. The alloimmunization rate of 9.8% among these participants is high, and appears in both D(+) and D(−) women. The other Rhesus antigens are seen to cause alloimmunization, with antigen e causing the highest prevalence. In conclusion, there is a need to identify antibodies and study the outcome for clinical significance, especially in D(+) women, to facilitate proper pregnancy management.
format Online
Article
Text
id pubmed-9719281
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97192812022-12-04 Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda Mbalibulha, Yona Natukunda, Bernard Okwi, Andrew Livex Kalyango, Joan N Isaac, Kajja Ononge, Sam J Blood Med Original Research INTRODUCTION: Maternal red cell alloimmunization to Rh antigen in pregnant women occurs when the immune system is sensitized by foreign red blood cell surface antigens, in this case fetal red blood cells, inducing an immune response. Various antigens of blood group systems may cause alloimmunization, especially the Rh, Kel, Fy, JK, and MNS systems. This study aimed to determine alloimmunization to the different frequencies of Rh antigen among pregnant women in South Western Uganda. METHODS: A total of 1369 pregnant women consented and were recruited into a cross-sectional study during their regular antenatal visits during the period August 2020 to July 2021. Samples (4 mL) of anticoagulated and coagulated blood were obtained, and Rh blood grouping including Rh antigen and the indirect antiglobulin test (IAT) was carried out using the agglutination technology of the LISS ID-Card technique in the Ortho Biovue ID-Micro Typing System. RESULTS: Out of 1369 participants recruited to the study, 78 (5.7%) were D(−), 1291 were D(+), and 134 (9.8%) had alloantibodies. Among those with alloantibodies, 115 (85.8%) were D(+) and 19 (14.2%) D(−). The percentage alloimmunization according to the Rh antigens was highest in e (9.72%), c (2.48%), C (2.34%) and E (0.94%) antigens. With the ABO system, alloimmunization was highest in blood group B (10.7%), followed by A (10.6%), O (9.2%) and then AB (7.1%). Alloimmunization was more prevalent in D(−) (24%) than in D(+) participants (8.9%). Rhesus antigen e was the most prevalent antigen (99.8%), followed by c. The alloimmunization rate of 9.8% among these participants is high, and appears in both D(+) and D(−) women. The other Rhesus antigens are seen to cause alloimmunization, with antigen e causing the highest prevalence. In conclusion, there is a need to identify antibodies and study the outcome for clinical significance, especially in D(+) women, to facilitate proper pregnancy management. Dove 2022-11-29 /pmc/articles/PMC9719281/ /pubmed/36471679 http://dx.doi.org/10.2147/JBM.S385737 Text en © 2022 Mbalibulha et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mbalibulha, Yona
Natukunda, Bernard
Okwi, Andrew Livex
Kalyango, Joan N
Isaac, Kajja
Ononge, Sam
Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda
title Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda
title_full Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda
title_fullStr Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda
title_full_unstemmed Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda
title_short Alloimmunization to Rh Antigen (D, C, E, C, E) Among Pregnant Women Attending Antenatal Care in South Western Uganda
title_sort alloimmunization to rh antigen (d, c, e, c, e) among pregnant women attending antenatal care in south western uganda
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719281/
https://www.ncbi.nlm.nih.gov/pubmed/36471679
http://dx.doi.org/10.2147/JBM.S385737
work_keys_str_mv AT mbalibulhayona alloimmunizationtorhantigendceceamongpregnantwomenattendingantenatalcareinsouthwesternuganda
AT natukundabernard alloimmunizationtorhantigendceceamongpregnantwomenattendingantenatalcareinsouthwesternuganda
AT okwiandrewlivex alloimmunizationtorhantigendceceamongpregnantwomenattendingantenatalcareinsouthwesternuganda
AT kalyangojoann alloimmunizationtorhantigendceceamongpregnantwomenattendingantenatalcareinsouthwesternuganda
AT isaackajja alloimmunizationtorhantigendceceamongpregnantwomenattendingantenatalcareinsouthwesternuganda
AT onongesam alloimmunizationtorhantigendceceamongpregnantwomenattendingantenatalcareinsouthwesternuganda